Algert Global’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,676
| Closed | -$1.29M | – | 1288 |
|
|
2025
Q1 | $1.29M | Sell |
11,676
-22,490
| -66% | -$2.49M | 0.03% | 721 |
|
|
2024
Q4 | $4.66M | Buy |
34,166
+15,800
| +86% | +$2.16M | 0.11% | 306 |
|
|
2024
Q3 | $2.12M | Buy |
+18,366
| New | +$2.12M | 0.06% | 531 |
|
|
2024
Q2 | – | Sell |
-2,042
| Closed | -$282K | – | 1565 |
|
|
2024
Q1 | $282K | Sell |
2,042
-2,140
| -51% | -$296K | 0.01% | 903 |
|
|
2023
Q4 | $551K | Buy |
4,182
+2,220
| +113% | +$292K | 0.02% | 793 |
|
|
2023
Q3 | $221K | Sell |
1,962
-15,244
| -89% | -$1.72M | 0.01% | 951 |
|
|
2023
Q2 | $1.62M | Buy |
+17,206
| New | +$1.62M | 0.07% | 468 |
|